8th Annual International Electromaterials Science Symposium, AIIM building, Innovation Campus, Wollongong.
|14 February||ACES Fabrication Fellowship launched. South Australia-based SMR Technologies will be the first Australian manufacturing company to put its workforce at the heart of scientific innovation as part of an eight-week fellowship program at ACES in Wollongong.|
Leon-Kane Maguire Address, AIIM building, Innovation Campus, Wollongong. “A giant in science and a giant in life”. With those words Professor Ray Baughman from the University of Texas at Dallas and Australian Centre of Excellence for Electromaterials Science collaborator summed up his long-time friend Leon Kane-Maguire.Professor Baughman, a leader in the research field of carbon nanotubes, delivered the Leon Kane-Maguire address in 2013.
|19 February||Launch of ACES-AM CRC Alliance, AIIM building, Innovation Campus, Wollongong. The ARC Centre of Excellence for Electromaterials Science (ACES) joined forces with Advanced Manufacturing CRC (AM CRC) in an alliance that will embrace critical market insights for the manufacturing industry. The partnership will leverage a new, world-class Additive Biofabrication Facility built by the Australian National Fabrication Facility (ANFF) and ACES in Wollongong. Manufacturing has a vibrant and healthy future in the Illawarra through the development of next generation of technologies, delegates heard at the celebration of a double milestone for the ARC Centre of Excellence for Electromaterials Science (ACES).|
|3 May||Materials for AdBioFab, St Vincents Hospital Melbourne. The conference focused on how biomaterials research and additive fabrication are converging to deliver innovative solutions for new medical technologies.These will reduce technical development time and costs. The combination of nanomaterials science, high-speed data communications and additive manufacturing represent a potentially highly disruptive transformation of medical treatments and technologies.Transformation of this kind will bring both challenges and risks. It will lead to new businesses being created and new ways of thinking about medical treatment. Understanding policy will be critical and providing guidance to policy makers about how to adapt regulatory regimes will be extremely important. The conference goal was to accelerate early stage medical technology development and help researchers and entrepreneurs understand how to make them investment ready. Professors Gordon Wallace (ACES Director), Mark Cook (St Vincent's Chair of Medicine) and Peter Choong (St Vincent's Chair of Surgery/Orthopaedics Director) detailed for the media the complex research collaborations being undertaken at ACES and St Vincent's, as well as the future implications of their cutting-edge biomaterials research.|